Clinical Trial Update: Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating optimization of tyrosine kinase inhibitor therapy and quality of life in Philadelphia-positive chronic myeloid leukemia patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Leukemia, Chronic Myeloid | Phase 3 | Status: COMPLETED